About this episode

Dr. Stephen Ansell discusses Waldenström macroglobulinemia, covering diagnosis, treatment, and management advancements.

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN Recorded on June 23, 2026 Stephen Ansell, MD, PhD Division Chair, Hematology Mayo Clinic Rochester, MN Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

More episodes of Treating Blood Cancers

• Mastocytosis: What Clinicians Need to Know · June 25, 2026 · 34 min
• CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support · June 15, 2026 · 42 min

Explore listener stats, chart rankings, contacts and more on the Treating Blood Cancers podcast page.